ReviewMolecular medicine (Cambridge, Mass.)2020
Erythropoietin as candidate for supportive treatment of severe COVID-19.
Hannelore Ehrenreich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papertrialcites it